CLINICAL_TRIALS
trial_result
· 2019-01-22
Clinical Trial Update: A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer [Phase 4]
Summary
Phase 4 translational study of Bevacizumab in metastatic colorectal cancer completed; results posted January 22, 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Colorectal Neoplasms | Phase 4 | Status: COMPLETED | Results posted: 2019-01-22